Cigna will no longer cover Mylan’s EpiPen and EpiPen Jr. autoinjectors, instead encouraging patients to use Impax ‘s generic device for treatment of severe allergic reactions. The move was effective as of Jan. 7, when Cigna released a list of changes to coverage for 2017.